Source: International Congress 2015 – Advances in asthma and allergy in animal models
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Hendrik Beckert, Helen Meyer-Martin, Ari Waisman, Roland Buhl, Michael Stassen, Christian Taube. A short splice variant of the tumor suppressor gene CYLD induces allergic airway disease in mice and is also expressed in humans. Eur Respir J 2015; 46: Suppl. 59, 2003

Member's Comments

No comment yet.

Related content which might interest you: IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Characterization of an endogenous Th17-cell generation during sensitization in the murine lung Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease Source: Annual Congress 2011 - T-cell subsets Year: 2011 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Deletion of peroxiredoxin 6 potentiates OVA-induced asthma epithelial-mesenchymal transition through EGFR pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA) Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 LATE-BREAKING ABSTRACT: MUC1 downregulation induces corticosteroid resistance in asthma’s in vitro and in vivo models Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 The development of an allergic airway disease is influenced by a short splice variant of CYLD Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Autoimmune induction of a COPD-like inflammatory phenotype in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Exosomal microRNAs in the serum are potential real-time biomarkers for allergic inflammation in the airway of mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Mapping a mouse model of severe asthma to human asthma using gene set variation analysis Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015